Client Resource, Longevity
Cardiorespiratory fitness is the single most powerful predictor of all-cause mortality available in sport science. The data is not ambiguous.
VO2 max, maximal oxygen uptake, is the measure of how efficiently your cardiovascular system can deliver oxygen to working muscles. In sport, it determines your aerobic ceiling. In medicine, it predicts your survival. The relationship between cardiorespiratory fitness and all-cause mortality is one of the most consistent findings in exercise epidemiology.
What makes the VO2 max data particularly compelling is its magnitude. Low fitness does not just modestly increase mortality risk. It increases it dramatically, by an amount that exceeds the risk associated with smoking, diabetes, and hypertension in large cohort studies.
A cohort study of 122,007 adults found that moving from the lowest fitness group to the next category produced a greater reduction in mortality risk than any other clinical intervention measured. There was no observed upper limit to the benefit of increasing fitness. (Mandsager et al., JAMA Network Open 2018)
This is not a lifestyle preference. Cardiorespiratory fitness is a measurable, trainable physiological variable with a direct and dose-dependent relationship to how long and how well you live.
The Mandsager et al. 2018 study, covering 122,007 adults followed for a median of 8.4 years, stratified participants into fitness categories based on objective treadmill testing. The results were stark. Moving from the lowest fitness category to above average was associated with a greater reduction in mortality risk than any traditional clinical risk factor, including smoking cessation, treatment of diabetes, and treatment of hypertension. The hazard ratio for low versus elite fitness was 5.04 after adjustment for all covariates. Comparable adjusted hazard ratios were 1.41 for smoking and 1.40 for diabetes. Low fitness, by this measure, kills more efficiently than either.
The number: Moving from low to above-average fitness was associated with an adjusted hazard ratio reduction that exceeded that of treating any single traditional risk factor measured in the study.
The relationship between cardiorespiratory fitness and mortality is not a U-curve. There is no point at which higher fitness becomes harmful from a longevity perspective. The Mandsager 2018 data showed that individuals with elite-level fitness (top 2.3% for age and sex) had significantly lower mortality than those in the high-fitness category, who in turn did better than the above-average group. This linearity holds all the way to the extremes of fitness. The implication is that more is better, up to whatever ceiling an individual can realistically achieve, and there is no "enough" threshold at which further improvement stops conferring benefit.
Practical implication: Do not stop trying to improve your aerobic fitness once it feels adequate. Every meaningful gain continues to confer longevity benefit.
VO2 max is expressed as millilitres of oxygen per kilogram of bodyweight per minute (ml/kg/min). It represents the maximum rate at which your heart, lungs, and muscles can absorb, transport, and utilise oxygen during maximal effort. It is determined by cardiac output (stroke volume x heart rate), the capacity of the blood to carry oxygen, and the ability of the muscles to extract and use it. All three are trainable through appropriate exercise. A typical untrained adult male in his 40s might score 35–40 ml/kg/min. A well-trained amateur endurance athlete might score 50–55. Elite endurance athletes score 70+. The mortality risk gradient is present across the entire distribution, not just at the extremes.
Reference ranges: For men aged 40–49: below average <33, average 33–42, above average 43–52, excellent >52 ml/kg/min. For women: below average <27, average 27–35, above average 36–44, excellent >44 ml/kg/min. (American College of Sports Medicine norms)
The association between VO2 max and survival reflects genuine causation through multiple pathways, not statistical confounding. Higher cardiorespiratory fitness is independently associated with reductions in coronary artery disease, hypertension, type 2 diabetes, atrial fibrillation, and several cancers. The mechanisms include improved insulin sensitivity, reduced systemic inflammation, better autonomic regulation, enhanced cardiac efficiency, and improved mitochondrial density and function. These benefits are not separable, a person who trains consistently enough to have good aerobic fitness receives all of them simultaneously. This systemic protection is why the mortality signal is so strong and so consistent across populations and study designs.
Key point: The benefit is not mediated entirely through weight loss or through any single mechanism. People with good fitness have lower mortality even after adjusting for BMI, smoking, and other risk factors.
VO2 max declines by approximately 1% per year from around age 25 in sedentary adults, and by roughly 0.5–0.7% per year in physically active adults. Over a decade, the gap between an active and sedentary person's aerobic fitness represents a functional age difference of 10–15 years or more. Critically, appropriate training can slow the decline significantly and, in previously untrained or detrained individuals, reverse it substantially in the short term. The ceiling for improvement diminishes with age, but meaningful gains remain achievable throughout life. The HERITAGE Family Study and other intervention data demonstrate that even moderate aerobic training in older adults produces significant VO2 max improvements.
Practical target: Consistent aerobic training (2–3 sessions weekly including one higher-intensity session) is sufficient to meaningfully slow age-related decline in most adults.
VO2 max responds most strongly to training that taxes the aerobic system near its upper limit. High-intensity interval training (HIIT) and zone 4–5 work produces the largest VO2 max improvements per unit of training time. The Norwegian 4x4 protocol (four intervals of 4 minutes at 85–95% maximum heart rate, with 3-minute active recovery) has consistently produced significant VO2 max gains in clinical and athletic populations. Moderate-intensity continuous training also improves VO2 max, particularly in untrained individuals, but at lower efficiency. For maximising longevity benefit, a combination of predominantly moderate-intensity aerobic work with regular high-intensity sessions appears optimal for both fitness and sustainability.
Minimum effective dose: 2 moderate-intensity sessions plus 1 high-intensity session weekly is sufficient to produce measurable VO2 max improvements in most previously inactive adults within 8–12 weeks.
Laboratory VO2 max testing requires a metabolic cart and involves exercising to exhaustion. A validated submaximal alternative uses a ramp test protocol with heart rate and workload data to extrapolate estimated VO2 max (eVO2 max). The Benchmark's Engine pillar uses a Wattbike ramp test with calibrated respiratory gas analysis to give you an accurate VO2 max estimate, contextualised against age and sex norms. Consumer wearables (Garmin, Apple Watch, Polar) also estimate VO2 max from heart rate during activity, with varying accuracy. The estimates are more useful for tracking trends over time than for precise absolute values. If you do not know your VO2 max and you are over 35, finding out is one of the most useful health assessments you can have.
At The Benchmark: VO2 max is tested as part of the Engine pillar. You get an absolute value, an age and sex percentile, and a training prescription based on your actual aerobic ceiling.
That is not hyperbole. It is what the data from 120,000+ adults followed for nearly a decade says. Cardiorespiratory fitness is modifiable, measurable, and more strongly associated with how long you live than smoking, diabetes, or heart disease individually.
You do not need to become an endurance athlete. You need to not be in the lowest fitness category. And then, if you are serious about longevity, you keep moving up.
Measure yours at The Benchmark →Mandsager K, Harb S, Cremer P et al., Association of cardiorespiratory fitness with long-term mortality among adults undergoing exercise treadmill testing. JAMA Network Open 2018;1(6):e183605. The primary 122,007-patient cohort study. Open access.
Kokkinos P, Myers J, Exercise and physical activity: clinical outcomes and applications. Circulation 2010;122:1637–1648. Review of the dose-response relationship between fitness and cardiovascular outcomes.
Blair SN, Kohl HW, Paffenbarger RS et al., Physical fitness and all-cause mortality: a prospective study of healthy men and women. JAMA 1989;262:2395–2401. The foundational study establishing the fitness-mortality link.
Ross R et al., Importance of assessing cardiorespiratory fitness in clinical practice: a case for fitness as a clinical vital sign. Circulation 2016;134:e653–e699. American Heart Association scientific statement on CRF as a clinical measure.
Wisloff U et al., Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients. Circulation 2007;115:3086–3094. The Norwegian 4x4 interval protocol evidence.